| Structure | Chemical Name | CAS | MF |
|
N-[2-(Dimethylamino)ethyl]-3-(acetylamino)-1,8-naphthalenedicarbimide
|
69409-02-5
|
C18H19N3O3
|
|
TAU-FLUVALINATE
|
69409-94-5
|
C26H22ClF3N2O3
|
|
2-Fluoro-4-(trifluoromethyl)aniline
|
69409-98-9
|
C7H5F4N
|
|
3-AMINO-5-CHLOROBENZOTRIFLUORIDE
|
69411-05-8
|
C7H5ClF3N
|
|
4-CHLORO-2,6-DIFLUOROANILINE
|
69411-06-9
|
C6H4ClF2N
|
|
1-(4-CHLOROPHENOXY)-3-(BROMOMETHYL)BENZENE
|
69411-40-1
|
C13H10BrClO
|
|
2-Fluoro-4-nitrobenzotrifluoride
|
69411-67-2
|
C7H3F4NO2
|
|
4-Amino-2-fluorobenzotrifluoride
|
69411-68-3
|
C7H5F4N
|
|
Coenzyme A, lithium salt
|
69412-18-6
|
C21H37LiN7O16P3S
|
|
5-(2-Methyl-3-oxo-1-pentenyl)norborn-2-ene
|
69412-65-3
|
|
|
sodium 2-[[4-(benzylethylamino)phenyl]azo]benzothiazole-5-sulphonate
|
69412-86-8
|
C22H19N4NaO3S2
|
|
1H-Pyrazole, 1-(chloroacetyl)-3-methyl- (9CI)
|
69413-05-4
|
C6H7ClN2O
|
|
1H-Pyrazole, 1-(2-bromo-1-oxopropyl)-3-methyl- (9CI)
|
69413-07-6
|
C7H9BrN2O
|
|
3-methyl-1-(3-nitrobenzoyl)-1H-pyrazole
|
69413-22-5
|
C11H9N3O3
|
|
3,5-dimethyl-1-(3-nitrobenzoyl)-1H-pyrazole
|
69413-23-6
|
C12H11N3O3
|
|
9,11-DIOXO-15S-HYDROXY-PROST-13E-EN-1-OIC ACID
|
69413-73-6
|
C20H32O5
|
|
1,6-dichloro-1,6-dideoxyfructose
|
69414-08-0
|
C6H10Cl2O4
|
|
4-METHYLUMBELLIFERYL ALPHA-L-ARABINOPYRANOSIDE
|
69414-26-2
|
C15H16O7
|
|
EOSIN-5-IODOACETAMIDE
|
69414-31-9
|
C22H10Br4INO6
|
|
Piridicillin
|
69414-41-1
|
C32H35N5O11S2
|
|
Piperazine, 1-acetyl-, Monohydrochloride
|
69414-53-5
|
C6H13ClN2O
|
|
2-[(4-Chloro-2-nitrophenyl)aMino]benzoyl Chloride
|
69414-55-7
|
C13H8Cl2N2O3
|
|
4-THIAZOLIDINONE, 5-[[2-CHLORO-3-[(3-ETHYL-2(3H)-BENZOTHIAZOLYLIDENE)ETHYLIDENE]-1-CYCLOHEXEN-1-YL]METHYLENE]-3-ETHYL-2-THIOXO-
|
69415-10-7
|
C23H23ClN2OS3
|
|
(((3E)-2-CHLORO-3-[(2Z)-2-(3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE)ETHYLIDENE]CYCLOHEX-1-EN-1-YL)METHYLENE)MALONONITRILE
|
69415-11-8
|
C21H18ClN3S
|
|
2-[(E)-2-(2-CHLORO-3-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-5-METHYL-1-CYCLOHEXEN-1-YL)ETHENYL]-3-ETHYL-1,3-BENZOTHIAZOL-3-IUM IODIDE
|
69415-12-9
|
C29H30ClIN2S2
|
|
2-[(E)-2-(2-CHLORO-3-((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)-1-CYCLOPENTEN-1-YL)ETHENYL]-3-ETHYL-1,3-BENZOTHIAZOL-3-IUM PERCHLORATE
|
69415-16-3
|
C27H26Cl2N2O4S2
|
|
2-(2,6-BIS((E)-2-[3-ETHYL-1,3-BENZOTHIAZOL-2(3H)-YLIDENE]ETHYLIDENE)CYCLOHEXYLIDENE)MALONONITRILE
|
69415-28-7
|
C31H28N4S2
|
|
2-((E)-2-(2-CHLORO-3-[(E)-2-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)ETHYLIDENE]-1-CYCLOPENTEN-1-YL)ETHENYL)-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
|
69415-30-1
|
C31H34Cl2N2O4
|
|
D-(-)-A-4-HYDROXYPHENYLGLYCINE DANE SALT METHYL POTASSIUM
|
69416-61-1
|
C13H16KNO5
|
|
1-Azetidinepropanoic acid butyl ester
|
69416-69-9
|
C10H19NO2
|
|
2-[(1-(2-PYRIDINYL)-ETHYL)SULFO]-5-METHYLBENZIMIDAZOLE
|
69417-07-8
|
C15H15N3O3S
|
|
Iodoniumdicollidineperchlorate
|
69417-67-0
|
C16H22ClIN2O4
|
|
Polyquaternium-33
|
69418-26-4
|
C11H21ClN2O3
|
|
heptabromo-9H-fluorene
|
69418-53-7
|
C13H3Br7
|
|
[N,N',N'',N'''-tetrakis(3-methoxypropyl)-29H,31H-phthalocyaninetetrasulphonamidato(2-)-N29,N30,N31,N32]copper
|
69418-68-4
|
C48H52CuN12O12S4
|
|
R,R-Fenoterol
|
69421-37-0
|
C17H21NO4
|
|
dimocifon
|
69422-71-5
|
C22H24N6O6S
|
|
2,4,6-TRICHLORONICOTINIC ACID
|
69422-72-6
|
C6H2Cl3NO2
|
|
2,4,6-trichloronicotinoyl chloride
|
69422-73-7
|
C6HCl4NO
|
|
1-(4-PHENOXY-PHENYL)-PYRROLE-2,5-DIONE
|
69422-82-8
|
C16H11NO3
|
|
pyridine-2,6-dipropanol
|
69423-13-8
|
C11H17NO2
|
|
ISOPROPYL-PHENYL-PHOSPHINIC ACID METHYL ESTER
|
69423-58-1
|
C10H15O2P
|
|
6 alpha-tigloyloxychaparrinone
|
69423-71-8
|
C31H38O12
|
|
O,O'-diacetylhematoporphyrin
|
69423-76-3
|
C38H42N4O8
|
|
Prifelone
|
69425-13-4
|
C19H24O2S
|
|
1,1-Dimethoxy-2-nitroethane
|
69425-53-2
|
C4H9NO4
|
|
(3β,22E)-3,25-Dihydroxy-cholesta-5,22-dien-24-one 3-Acetate
|
69425-74-7
|
C29H44O4
|
|
(3β,22E,24ξ)-Ergosta-5,22-diene-3,24,25-triol 3-Acetate
|
69425-75-8
|
C30H48O4
|
|
(3β,22E)-Ergosta-5,7,22-triene-3,24,25-triol 3-Acetate
|
69425-77-0
|
C30H46O4
|
|
2-(14-carboxytetradecyl-N-ethyl maleic ester)-2-ethyl-4,4-dimethyl-3-oxazolidinyl oxyl
|
69425-84-9
|
C28H47N2O6*
|
|
2-(Butylthio)-4-(4-methoxyphenyl)thiazole
|
69426-52-4
|
|
|
13-cis-Etretinate
|
69427-41-4
|
C23H30O3
|
|
13-CIS-ACITRETIN
|
69427-46-9
|
C21H26O3
|
|
2-amino-2-deoxy-beta-arabinofuranosyladenine
|
69427-80-1
|
|
|
2-amino-2-deoxy-beta-arabinofuranosylguanine
|
69427-81-2
|
C10H14N6O4
|
|
Acid Brown 119
|
69428-27-9
|
C13H18
|
|
|
Doxorubicin Impurity 6
|
69429-21-6
|
C26H27NO11
|
|
9-hydroxy-7,7-dimethyl-9$l^{3}-ioda-8-oxabicyclo[4.3.0]nona-1,3,5-trie ne
|
69429-70-5
|
C9H11IO2
|
|
Cilobamine
|
69429-84-1
|
C17H23Cl2NO
|
|
Cilobamine
|
69429-85-2
|
C18H27Cl2NO4S
|
|
|
TEA-MYRISTOYL HYDROLYZED COLLAGEN
|
69430-23-5
|
|
|
|
Cyclicdimethylpolysiloxane
|
69430-24-6
|
|
|
|
Cyclosiloxanes, di-Me, polymers with Me Ph cyclosiloxanes and vinyl group-terminated di-Me siloxanes
|
69430-27-9
|
|
|
|
Cyclosiloxanes, di-Me, polymers with Me Ph cyclosiloxanes, Me vinyl cyclosiloxanes and vinyl group-terminated di-Me siloxanes
|
69430-28-0
|
|
|
|
HYDROCARBON, C6-20, POLYMERS)
|
69430-34-8
|
|
|
|
POLY(METHYLSTYRENE-CO-INDENE)
|
69430-35-9
|
(C45H78)n
|
|
Keratin hydrolyzed
|
69430-36-0
|
C2H2BrClO2
|
|
|
Siloxanes and Silicones, di-Me, hydroxy-terminated, reaction products with trimethoxymethylsilane and N-3-(trimethoxysilyl)propyl-1,2-ethanediamine
|
69430-37-1
|
|
|
|
dimethylsiloxane, 3-(trimethoxysilyl)-1-propanethiol
|
69430-38-2
|
|
|
|
Siloxanes and Silicones, di-Me, Me hydrogen, reaction products with hexamethyldisiloxane and polyethylene glycol monohydrogen (dodecenyl)butanedioate allyl ether
|
69430-39-3
|
|
|
|
Siloxanes and Silicones, di-Me, Me hydrogen, reaction products with hexamethyldisiloxane and polypropylene glycol allyl Me ether
|
69430-40-6
|
|
|
|
dimethylsiloxane, (2-naphthyloxy)-terminated
|
69430-42-8
|
|
|
|
dimethylsiloxane/hexamethylcyclotrisiloxane/fluorosilicone
|
69430-43-9
|
|
|
|
Siloxanes and Silicones, di-Me, reaction products with polyethylene glycol monoallyl ether and 1,1,3,3-tetramethyldisiloxane
|
69430-45-1
|
|
|
|
dimethylsiloxane/ hexamethyldisiloxane/ methyl siloxanes
|
69430-46-2
|
|
|
Siloxanes and Silicones, di-Me, reaction products with Me hydrogen siloxanes and 1,1,3,3-tetramethyldisiloxane
|
69430-47-3
|
C5H16O2Si2
|
|
|
DIMETHYL POLYSILOXANE-DIMETHYL HYDROGEN TERMINATED
|
69430-48-4
|
|
|
|
3-hydroxypropylmethylsiloxane, ethoxylated
|
69430-50-8
|
|
|
EINECS 263-004-3
|
69430-53-1
|
C20H34Cl8
|
|
Butyl epoxystearate (VAN)
|
69430-58-6
|
C22H42O3
|
|
|
Iron alloy, base, (15Kh16N15R)
|
69430-86-0
|
|
|
|
DELTA SLEEP-INDUCING PEPTIDE
|
69431-45-4
|
C35H48N10O15
|
|
|
gastrozymin
|
69431-52-3
|
|
|
|
MONAFAX 785
|
69431-60-3
|
|
|
1,1'-Diacetyl-2,3-dihydro-2,5,5',10,10'-pentahydroxy-2,2'-dimethyl[9,9'-bianthracene]-4,4'(1H,1'H)-dione
|
69431-87-4
|
C34H28O9
|
|
4,4'-[Azobis(4,1-phenyleneazo)]bis[N,N,3,5-tetramethylbenzenamine]
|
69432-31-1
|
C32H36N8
|
|
4,4'-[Azobis(4,1-phenyleneazo)]bis[N,N-diethyl-3-methylbenzenamine]
|
69432-33-3
|
C34H40N8
|
|
4,4'-[Azobis[4,1-phenyleneazo(2,5-dimethyl-4,1-phenylene)azo]]bis[N-ethyl-1-naphthalenamine]
|
69432-35-5
|
C52H48N12
|
|
2-(4-METHOXY-1-NAPHTHYL)-4,6-BIS(TRICHLOROMETHYL)-1,3,5-TRIAZINE
|
69432-40-2
|
C16H9Cl6N3O
|
|
2-(4-ethoxy-1-naphthyl)-4,6-bis-(trichloromethyl)-1,3,5-triazine
|
69432-41-3
|
C17H11Cl6N3O
|
|
2-[1,1'-biphenyl]-4-yl-4,6-bis(trichloromethyl)-1,3,5-triazin-2-acetamide
|
69432-53-7
|
C19H13Cl6N4O
|
|
3,5-Cyclohexadiene-1,2-diol, 4-(4-hydroxyphenyl)- (9CI)
|
69432-59-3
|
C12H12O3
|
|
3,5-Cyclohexadiene-1,2-diol, 4-(3-hydroxyphenyl)- (9CI)
|
69432-60-6
|
C12H12O3
|
|
1,2,6,7,8-PNCDF
|
69433-00-7
|
C12H3Cl5O
|
|
1-Piperazinecarbonyl chloride (9CI)
|
69433-07-4
|
C5H9ClN2O
|
|
Acetic acid,aminothioxo-,phenylmethyl ester (9CI)
|
69433-18-7
|
C9H9NO2S
|
|
Acetic acid, imino(phenylamino)- (9CI)
|
69433-23-4
|
C8H8N2O2
|
|
di-(2-amino-5-nitrothiazole)dichloroplatinum(II)
|
69433-99-4
|
C6H6Cl2N6O4PtS2
|
|
2,3-Pentanedione, 5-hydroxy-, 3-oxime (9CI)
|
69435-39-8
|
C5H9NO3
|
|
5H-Pyrido[3,2-b]azepine-5-carbothioamide, 6,7,8,9-tetrahydro-
|
69435-46-7
|
C10H13N3S
|